Bicara Therapeutics (BCAX) Director Christy Oliger Receives Award

What Happened

• Christy Oliger, a director of Bicara Therapeutics, received a grant of 38,950 derivative shares (an equity award) on July 28, 2026. The award was issued at a $0.00 per-share price (total recorded value $0) and reported on a Form 4 filed 2026-07-29. This is an equity award (not an open-market purchase or sale).

Key Details

• Transaction date: July 28, 2026; Form 4 filed: July 29, 2026.
• Transaction type: Award/Grant of derivative securities (code A); price per share reported $0.00; total value $0.
• Shares granted: 38,950 derivative shares.
• Shares owned after transaction: Not specified in the provided filing information.
• Vesting: Per footnote — one-third vests on July 28, 2027; the remainder vests in 24 equal monthly installments thereafter, subject to continued service.
• Timeliness: Filing appears timely (reported the next day); no late-filing flag noted.

Context

• This was a time‑based equity grant to a director, typically part of compensation or retention arrangements; it does not represent an open‑market buy or sale. Because the award vests over time, the director must remain in service for the shares to become exercisable/owned. No sale or cashless exercise was reported in this filing.